In particular, the occurrence of vasoactive intestinal polypeptide (2, 3), GnRH (4), somatostatin (5), TRH (4, 6), as well as their corresponding mRNAs (7-11) has been demonstrated in the rat anterior pituitary. In contrast, the biosynthesis of hypothalamic neuropeptides in the intermediate lobe of the pituitary has received little attention (12, 13).
In particular, the occurrence of vasoactive intestinal polypeptide (2, 3) , GnRH (4), somatostatin (5), TRH (4, 6) , as well as their corresponding mRNAs (7) (8) (9) (10) (11) has been demonstrated in the rat anterior pituitary. In contrast, the biosynthesis of hypothalamic neuropeptides in the intermediate lobe of the pituitary has received little attention (12, 13) .
The primary structure of somatostatin-14 (SS1) has been remarkably well conserved during vertebrate evolution and it has long been thought that only one form of somatostatin existed in tetrapods (see Refs. 14 and 15 for reviews). However, the characterization of two isoforms of somatostatin in the brain of the frog Rana ridibunda, i.e. SS1 and the variant [Pro 2 ,Met 13 ]somatostatin-14 (SS2), has shown that this view was not correct (16) . Molecular cloning of the cDNAs encoding prepro-SS1 (PSS1) and prepro-SS2 (PSS2) in the brain of fish (17) (18) (19) , amphibians (20) , and mammals (21-23) has revealed that two somatostatin genes are actually expressed in the central nervous system of all vertebrates. While the C-terminal tetradecapeptides of PSS1 and PSS2 exhibit strong structural similarity (e.g. only two amino acid substitutions between SS1 and SS2 in frog), the sequences of the N-terminal flanking peptides strongly diverge. Notably, in the frog R. ridibunda, PSS2 by contrast to PSS1 does not contain a processing site within the N-flanking domain and thus cannot generate an extended form, which would be homologous to somatostatin-28 ( Fig. 1) .
In a previous report, we have shown that the mRNAs encoding PSS1 and PSS2 are differentially distributed in frog tissues. Specifically, the PSS1 gene is widely expressed in the CNS and in peripheral organs including the pancreas and gastrointestinal tract while the expression of the PSS2 gene seemed to be restricted to the brain (20) . In the present study, we demonstrate that, in frog, the PSS2 gene but not the PSS1 gene, is intensely expressed in melanotrope cells, and we show that PSS2 is fully processed to generate the SS2 peptide in the intermediate lobe of the pituitary.
Materials and Methods Animals
Adult male frogs (R. ridibunda, 30 -40 g body weight) were obtained from a commercial source (Couétard, Saint-Hilaire de Riez, France). The animals were kept in glass tanks supplied with tap water in a temperature-controlled room (8 Ϯ 0.5 C) under an established photoperiod (lights on, 0600 -1800 h) for at least 1 wk before the experiments. Animal manipulations were performed according to the recommendations of 
Northern blot analysis
Total RNAs from whole brain, whole pituitary, distal lobe, and neurointermediate lobe were prepared by the acid guanidinium thiocyanate-phenol-chloroform method (24) using the Tri reagent (Sigma, SaintQuentin-Fallavier, France). Equivalent amounts of RNA (20 g) were analyzed as previously described (20) and hybridized under high stringency conditions with 32 P-labeled random primed PSS1 and PSS2 cDNA probes.
In situ hybridization
Frogs were anesthetized by immersion in a solution of 0.1% triaminobenzoic acid ethyl ester (MS 222, Sigma) and perfused transcardially with 0.1 m PBS (pH 7.4) and then with 4% paraformaldehyde in PBS. Whole pituitaries were quickly removed and postfixed in the same fixative solution for 4 h. The tissues were immersed in 0.1 m PBS containing 15% sucrose for 12 h and transferred into a 30% sucrose solution for 12 h. The pituitaries were embedded in O.C.T. Tissue Teck (ReichertJung, Nussloch, Germany) and frozen on dry ice. Frontal sections (12-m thick) were cut in a cryomicrotome (Frigocut 2800 E, Reichert-Jung) and mounted on 0.5% gelatin/0.05% chrome alum/0.01% poly-l-lysinecoated slices. Tissue sections were processed for in situ hybridization as previously described (20) . Briefly, sections were incubated in 0.1 m triethanolamine (pH 8.0) for 5 min, rinsed in 2ϫ standard saline citrate (SSC; 0.3 m NaCl/0.03 m sodium citrate, pH 7.0), and covered with prehybridization buffer (50% formamide; 0.6 m NaCl; 10 mm Tris-HCl, pH 7.5), containing 0.02% Ficoll, 0.02% polyvinylpyrollidone, 0.1% BSA, 1 mm EDTA (pH 8.0), supplemented with 550 g/ml denatured salmon sperm DNA and 50 g/ml yeast tRNA. All sections were hybridized with a [
35 S]uridine-5Ј-triphosphate-labeled PSS1 or PSS2 riboprobe synthesized as previously described (20) . Hybridization was performed overnight at 60 C in the same buffer (except for salmon sperm, whose concentration was 60 g/ml) supplemented with 10 mm dithiothreitol, 10% dextran sulfate, and 10 7 cpm/ml heat-denatured riboprobes. The sections were washed in 2ϫ SSC at 60 C and treated with ribonuclease A (50 g/ml) for 60 min at 37 C. Five final high stringency washes were performed in 0.1ϫ SSC, 14 mm ␤-mercaptoethanol, 0.05% sodium pyrophosphate at 60 C. Pituitary slices were dehydrated in graded ethanols with salts and exposed onto Hyperfilm-␤max (Amersham Pharmacia Biotech, Les Ulis, France) for 2 wk. Tissue sections were subsequently dipped into Kodak (Rochester, NY) NTB-2 liquid emulsion, exposed for 4 wk, and developed. The slices were stained with hematoxylin and eosin for identification of anatomical structures.
Peptide synthesis and production of antibodies
Synthetic frog SS2, PPSVKFPRLSLRE (PSS2 54 -66 ) ( Fig. 1 ) and its Ntyrosylated analog ([Tyr 0 ] PSS2 54 -66 ) were synthesized by solid phase methodology as previously described (25) . Synthetic PSS2 54 -66 (5 mg) was conjugated to 100 mg bovine thyroglobulin using glutaraldehyde as a coupling agent. After a 2-h incubation in 0.1 m PBS (pH 7.5) at 4 C, the conjugate was dialyzed. The coupling efficiency was 75%. Rabbits were injected intradermally with the synthetic peptide-thyroglobulin conjugate (equivalent of 200 g synthetic peptide/animal per injection) emulsified with Freund's adjuvant. The titer of the antisera was determined by RIA as described below. The same antiserum (no. 49075) was used for immunohistochemical labeling and RIA quantification. The SS1 antiserum (no. SAB3638) was kindly provided by Dr. C. Rougeot (Institut Pasteur, Paris, France) (26) . The specificity of this antibody has been previously characterized. This antiserum exhibits 60% cross-reactivity in RIA with the frog SS2 variant.
Immunohistochemistry
Frogs were anesthetized and perfused transcardially with 100 ml of 0.1 m PBS as indicated above. The perfusion was continued with 100 ml of McLean's fixative as previously described (27) . The whole brains with the attached pituitaries were quickly dissected and postfixed overnight at 4 C with the same fixative solution. The tissues were immersed in 0.1 m PBS containing 15% sucrose for 12 h and transferred into 30% sucrose for 12 h. The tissues were embedded in O.C.T. Tissue Teck and frozen on dry ice. Frontal and parasagittal sections (10-m thick) were cut in a cryomicrotome and mounted on glass slides coated with 0.5% gelatin and 5% chrome alum. Slices were rehydrated and processed for indirect immunofluorescence as previously described (28) . Briefly, the sections were preincubated with normal goat serum (1:30) for 45 min to reduce nonspecific staining, and incubated in a moist chamber for 12 h at 4 C with either the SS1 or the PSS2 54 -66 antiserum both diluted 1:400 in 0.1 m PBS containing 0.3% Triton X-100 and 1% BSA. The sections were rinsed three times, incubated for 90 min at room temperature with fluorescein isothiocyanate-conjugated goat antirabbit ␥-globulins (Nordic Immunology, Tilburg, The Netherlands), diluted 1:100 in PBS. The slices were finally mounted in PBS-glycerol (1:1, vol/vol). The preparations were examined under a Leitz Orthophan microscope equipped with a VarioOrthomat photographic system. Selected slices were also analyzed with a confocal laser scanning microscope (Leica Corp., Heidelberg, Germany) equipped with a diaplan optical system and an argon/krypton ion laser (excitation wavelengths: 488, 568, and 610 nm). To study the specificity of the immunoreaction, the following controls were performed: 1) substitution of the primary antisera with PBS; 2) incubation with nonimmune rabbit serum instead of the primary antisera; 3) preincubation of the SS1 antiserum with synthetic SS1 or SS2 (10 Ϫ6 m each) 
Tissue extraction and peptide characterization
Frog pituitaries were boiled in acetic acid for 10 min to ensure inactivation of proteolytic enzymes (29) . The tissues were homogenized by sonication, and the suspension was centrifuged (13,000 ϫ g; 4 C; 30 min). Peptide material contained in the supernatant was prepurified on SepPak C 18 cartridges (Waters Associates, Milford, MA). Bound material was eluted with acetonitrile-water-trifluoroacetic acid (60:39.96:0.04, vol/vol/vol) and evaporated in a Speed-Vac concentrator (Savant, Hicksville, NY). The dry extract was dissolved in water-trifluoroacetic acid (99.9:0.1, vol/vol) and chromatographed on a (250 ϫ 4.6-mm) Vydac 218TP54 C 18 reversed-phase HPLC column at a flow rate of 1 ml/min. The concentration of acetonitrile in the eluting solvent was raised from 21-42% over 60 min for characterization of SS1 and SS2 and from 3.5-68.5% over 60 min for characterization of PSS2 54 -66 . Oneminute fractions were collected and dried in a Speed-Vac concentrator. Synthetic SS1 and SS2 used as reference peptides were chromatographed using the same gradient as for pituitary extracts.
RIA procedures
The concentrations of SS1-and PSS2 54 -66 -like immunoreactivity in crude tissue extracts or HPLC fractions were measured by RIA using antisera nos. SAB3638 and 49075, respectively. Synthetic [Tyr 0 ] SS1 and [Tyr 0 ] PSS2 54 -66 (1 g each) were iodinated by the chloramine-T method and separated from free iodine on Sep-Pak cartridges. The radioiodinated peptides were eluted with a gradient of acetonitrile (0 -60%) and kept at -20 C in glycerol (1:1, vol/vol). The RIAs were performed in 0.06 m Na 2 HPO 4 containing 0.01 m disodium EDTA, 0.5% NaN 3 and 0.1% Triton X-100 (30) . The final dilutions of the antisera against SS1 and PSS2 54 -66 were 1:18,000 and 1:5,400, respectively, and the total amount of tracer was 8,000 cpm/tube. The incubation was carried out for 48 h at 4 C. Separation of the antibody-bound fraction was performed by adding 100 l of bovine ␥-globulins (1%) and 2 ml of polyethylene glycol 8,000 (20%). The tubes were maintained 20 min at room temperature and centrifuged (5,000 ϫ g; 4 C; 25 min). The supernatants were removed and the precipitates containing the bound fraction were counted in a ␥ counter (LKB Wallac, Inc., Rockville, MD).
Background color adaptation experiments
Ninety frogs were adapted on white (40 animals) or black background (50 animals) under constant illumination for 3 wk at 8 C. The neurointermediate lobes of the pituitary from four and five groups of ten whiteor black-adapted animals were dissected and immediately processed for RNA extraction. RNA samples were analyzed by Northern blot using PSS2 or proopiomelanocortin (POMC) cDNAs probes. mRNA signals were quantified and corrected for RNA loading variations by scanning the ethidium-bromide-stained 18S ribosomal RNA of each sample using the Densylab 2.0.5 software (Bioprobe Systems, Montreuil, France). Statistical analysis was performed using the Student's t test.
Perifusion experiments
The perifusion technique used to determine the effect of test substances on ␣-MSH release has been previously described in detail (31) . For each experiment, four neurointermediate lobes (NILs) were mixed with preswollen Bio-Gel P-2 beads and transferred into a plastic column (0.9 cm inner diameter). The tissues were perifused with Ringer's solution at constant flow rate (0.3 ml/min) and temperature (24 C). The effluent perifusate was collected as 2.5-min fractions during infusion of the secretagogues and 5-min fractions during stabilization periods. The collected samples were immediately chilled at 4 C, and the concentration of ␣-MSH was measured in each fraction on the same day as the perifusion experiment as previously described (32) . The perifusion profiles were calculated and expressed as percentages of the basal secretory level. The basal level of ␣-MSH was calculated as the mean of six consecutive fractions (30 min) collected just before the infusion of each secretagogue.
Results

Distribution of frog PSS1 and PSS2 mRNAs
The tissue distribution of the PSS1 and PSS2 mRNAs was investigated by Northern blot analysis. Using the PSS1 cDNA probe, hybridization signals corresponding to mRNA species of approximately 750 nucleotides were observed in the brain, but not in the pituitary (Fig. 2A) . Using the PSS2 cDNA probe, a weak hybridization signal (ϳ550 nucleotides) was detected in the brain, and an intense signal was seen in the neurointermediate lobe of the pituitary. No PSS2 hybridization signal was observed in the distal lobe of the pituitary (Fig. 2B) .
By means of in situ hybridization histochemistry, we did not detect PSS1 mRNA in the distal lobe, the intermediate lobe and the neural lobe of the pituitary (Fig. 3, A and D) . In contrast, a dense accumulation of PSS2 mRNA was seen in the intermediate lobe (Fig. 3B) . No hybridization signal was observed with the sense PSS2 riboprobe (Fig. 3C) . Cytoautoradiographic labeling confirmed that the three lobes of the pituitary were devoid of PSS1-expressing cells (Fig. 3E) , whereas the pars intermedia appeared densely loaded with PSS2 mRNA (Fig. 3F) .
Peptide concentration in frog pituitary extracts
The detection limit of the PSS2 54 -66 RIA was 40 pg/tube. The IC 50 value of the assay was 270 pg. Intra-and interassay coefficients of variation were 7.5% and 10%, respectively. The antibody did not exhibit any cross-reactivity with SS1, frog SS2, ␣-MSH, rat octadecaneuropeptide, human pituitary adenylate cyclase-activating polypeptide (PACAP), mouse joining peptide, or human secretoneurin. Serial dilutions (1:2) of frog pituitary extracts produced displacement curves that were parallel to the standard curve obtained with synthetic PSS2 54 -66 (Fig. 4) . The total content of PSS2 54 -66 in Sep-Pak-prepurified extracts was 1.2 ng per pituitary gland.
FIG. 2.
Northern blot analysis of total frog RNA hybridized with the random-primed PSS1 (A) and PSS2 (B) cDNA probes. Twenty micrograms of RNA from each tissue sample were electrophoresed on a formaldehyde-agarose gel. Molecular weights were determined by using RNA markers.
Distribution of SS1 and PSS2 54 -66 in the frog pituitary
A dense network of SS1-immunoreactive fibers was observed in the neural lobe of the pituitary (Fig. 5A) . A few SS1-positive fibers were also detected coursing between melanotrope cells (Fig. 5B) . The PSS2 54 -66 antiserum produced intense immunolabeling of melanotrope cells in the intermediate lobe of the pituitary (Fig. 5C) . At a higher magnification, the PSS2 54 -66 -immunoreactive material exhibited a granular aspect and appeared confined to the cytoplasm of melanotrope cells (Fig. 5D ). In contrast, no PSS2 54 -66 -like immunoreactivity was detected in the neural lobe (Fig. 5C) . The distal lobe of the pituitary was totally devoid of SS1-(data not shown) and PSS2 54 -66 -immmunoreactive material (Fig. 5C) .
Preincubation of the primary antiserum against SS1 with the homologous peptide (10 Ϫ6 m) resulted in complete loss of the immunostaining (Fig. 5E ). In contrast, preincubation of the SS1 antiserum with SS2 (10 Ϫ6 m) did not affect the immunolabeling in the neural lobe of the pituitary (Fig. 5F) . Preincubation of the antiserum against PSS2 54 -66 with synthetic PSS2 54 -66 (10 Ϫ6 m) totally abolished the immunoreaction in the intermediate lobe of the pituitary (data not shown).
Reversed-phase HPLC analysis
The PSS1-and PSS2-derived peptides present in the prepurified pituitary extracts were characterized by combining reversed-phase HPLC analysis and RIA detection. The SS1 RIA revealed the existence of two major peaks exhibiting a retention time of 25 min and 31 min. These two immunoreactive peptides coeluted with synthetic SS1 and SS2, respectively (Fig. 6A) . The PSS2 54 -66 RIA detected a predominant immunoreactive peak that eluted at 28 min (Fig. 6B) .
Effect of background adaptation on PSS2 and POMC gene expression
The expression of PSS2 and POMC mRNA in the intermediate lobe of the pituitary was compared in white-and black-adapted frogs by Northern blot analysis. No significant difference in PSS2 mRNA level was detected between the two groups of animals (P Ͼ 0.05; Fig. 7A ). In contrast, dark background adaptation provoked a significant increase (P Ͻ 0.01) in POMC mRNA level (Fig. 7B) .
Effect of SS2 on ␣-MSH release
As previously reported (33) , exposure of perifused frog neurointermediate lobes to TRH (10 Ϫ8 m) induced a marked stimulation of ␣-MSH release. In contrast, synthetic SS2 (10 Ϫ6 m) did not modify ␣-MSH secretion (Fig. 8A) . During infusion of SS2, the stimulatory effect of TRH was not affected (Fig. 8B ).
Discussion
Previous reports have shown that, in frog, the concentration of somatostatin-immunoreactive material is in the same range in the neurointermediate lobe as in the hypothalamus (34, 35 
Expression of the PSS2 gene in the frog pars intermedia
Using Northern blot analysis, PSS1 mRNA was found neither in the distal lobe nor in the neurointermediate lobe, and PSS2 mRNA was not detected in the distal lobe of the pituitary. In contrast, intense expression of the PSS2 gene was observed in the neurointermediate lobe. In situ hybridization histochemistry confirmed that the PSS2 transcripts were not detected in the distal lobe and revealed that PSS2 mRNA is exclusively expressed in the intermediate lobe of the pituitary. Although the existence of an SS2 ortholog, called cortistatin (CST), has now been documented in mammals (21) (22) (23) and fish (17) (18) (19) , transcription of the gene encoding this somatostatin variant in the pituitary has never been reported before. The present study thus provides the first evidence for selective and discrete expression of the PSS2 gene in the intermediate lobe of the pituitary.
Cellular localization of PSS2 in the frog pars intermedia
The pars intermedia of the frog pituitary is composed of two distinct populations of cells: the endocrine melanotrope cells that secrete POMC-derived peptides and glial-like cells called folliculo-stellate cells (37) . Recent studies conducted in mammals indicate that the somatostatin-14 precursor gene is expressed in folliculo-stellate cells (13) , whereas another hypothalamic hypophysiotropic neurohormone, PACAP, is expressed in melanotrope cells (38) . It was thus important to determine which cell type expresses the PSS2 gene in the frog pars intermedia. To solve this question, we have raised antibodies against a tridecapeptide derived from PSS2, i.e. PSS2 54 -66 . This peptide sequence was chosen because PSS2 54 -66 exhibits a very low degree of similarity to frog somatostatin-28 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] (Fig. 1 ) so that the antibodies should not cross-react with any PSS1-derived peptides. A sensitive RIA was developed, and it was found that the antibodies did not show any cross-reactivity with various peptides present in melanotrope cells such as ␣-MSH, octadecaneuropeptide, PACAP, joining peptide, and secretoneurin. The fact that hypophysial extracts produced displacement curves that were parallel to the standard curve revealed that peptides immunologically related to PSS2 are actually present in the pituitary.
The PSS2 54 -66 antibodies were then used to determine the cellular localization of the immunoreactive material in the frog pituitary. Intense labeling was observed throughout the intermediate lobe, whereas the distal lobe and the neural lobe were totally devoid of immunoreactivity. Confocal laser scanning microscope analysis revealed that PSS2 54 -66 -like immunoreactivity was restricted to the cytoplasmic domain of melanotrope cells. In contrast, the SS1-like immunoreactivity was contained in nerve fibers located in the neural lobe and in a few terminals innervating the intermediate lobe.
Consistent with this latter observation, somatostatin-14 positive fibers have previously been visualized in the pars intermedia of fish (39 -41) and amphibians (36) . In rat, somatostatin-14-like immunoreactivity has been visualized in folliculo-stellate cells of the pars intermedia (13) .
Processing of PSS2 in the frog pars intermedia
The mammalian ortholog of PSS2, pro-cortistatin (PCST), possesses two dibasic sites in its C-terminal region (21) . Transfection of the PCST cDNA in AtT-20 cells has recently shown that these two cleavage sites are used so that processing of PCST can generate both CST-14 and its elongated form CST-29 (42) . Unlike mammalian PCST, frog PSS2 only possesses one dibasic site located upstream the SS2 sequence (20) , and the mature peptide SS2 has been isolated from the frog brain (16) . To investigate whether PSS2 expressed in pars intermedia cells is actually processed to generate mature SS2, the immunoreactive peptides were characterized by combining HPLC analysis and RIA quantification. Using a RIA for SS1 that cross-reacts with SS2, two immunoreactive peptides, which exhibited the same retention as synthetic SS1 and frog SS2, were resolved. The presence of SS1 in neurointermediate lobe extracts is consistent with the occurrence of numerous SS1-immunoreactive terminals in the pars nervosa. Using the PSS2 54 -66 RIA, a single peak that likely cor- responds to PSS2 was resolved. The presence of both SS2 and PSS2 54 -66 -like immunoreactivity in neurointermediate lobe extracts indicates that the Arg-Lys processing site located upstream SS1 is efficiently cleaved by prohormone convertases (PCs). Because PC1 and PC2 are actively expressed in the frog pars intermedia (43) (44) (45) (46) (47) , either one or the other enzyme may be responsible for the processing of PSS2 in melanotrope cells.
Physiological implications
In amphibians, melanotrope cells play a pivotal role in skin color adaptation (37) . When animals are placed on a dark background, the transcription of the POMC gene is strongly activated (48) and the expression of several other genes, including chromogranins (49, 50), PC2 (51), and 7B2 (52) is also stimulated. Conversely, the present study has shown that the level of PSS2 mRNA in the frog pars intermedia is not affected during background color adaptation, indicating that the expression of POMC and PSS2 are not coordinately regulated.
The functional significance of SS2 produced by melanotrope cells is totally unknown. To explore this issue, we have investigated the possible role of SS2 on melanotrope cell activity. We found that SS2 had no effect on spontaneous or TRH-induced ␣-MSH secretion by perifused frog neurointermediate lobes, indicating that the peptide does not exert paracrine or autocrine activities. Consistent with this observation, we have previously found that SS1 does not affect ␣-MSH release in R. ridibunda (35) . Therefore, it appears that neither SS1 released by nerve terminals in the vicinity of melanotrope cells nor SS2 produced by melanotrope cells themselves are involved in the control of the ␣-MSH secretion.
The pars intermedia of the pituitary is poorly vascularized, and it is generally accepted that the peptide hormones secreted by melanotrope cells must diffuse to the adenohypophysis before being released into the systemic circulation. Thus, after reaching the distal lobe, SS2 may control the secretion of anterior pituitary hormones. In agreement with this hypothesis, we have recently shown that SS2, like SS1, is able to compete for [ 125 I-Tyr 0 ,d-Trp 8 ]S-14 binding in the distal lobe of the frog pituitary, and that both SS1 and SS2 inhibit cAMP formation and GH release from cultured frog adenohypophysial cells (53). These data, together with the occurrence of a dense accumulation of somatotrope cells in the frog distal lobe at the boundary of the intermediate lobe (54), strongly suggest that SS2 released by melanotrope cells, in addition to SS1 released by hypothalamic nerve fibers in the median eminence, may contribute to the regulation of GH secretion (Fig. 9) .
In conclusion, the present data have shown that the PSS2 gene, but not the PSS1 gene, is actively expressed in the frog pars intermedia. Immunohistochemical labeling combined with confocal laser scanning microscope analysis revealed that PSS2-like immunoreactivity is located in the cytoplasm of melanotrope cells. Biochemical characterization indicated that the immunoreactive peptide is indistinguishable from synthetic frog SS2. Collectively, these data suggest that frog melanotrope cells secrete the somatostatin variant 
